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Abstract
Background: α-Sarcin is a protein toxin produced by Aspergillus giganteus. It belongs to a family of
cytotoxic ribonucleases that inactivate the ribosome and inhibit protein synthesis. α-Sarcin cleaves
a single phosphodiester bond within the RNA backbone of the large ribosomal subunit, which
makes the ribosome unrecognizable to elongation factors and, in turn, blocks protein synthesis.
Although it is widely held that the protein synthesis inhibition caused by the toxin leads to cell
death, it has not been directly shown that catalytically inactive mutants of α-sarcin are non-toxic
when expressed directly within the cytoplasm of cells. This is important since recent studies have
cast doubt on whether protein synthesis inhibition is sufficient to initiate apoptosis.
Results: In this report, we assay α-sarcin cytotoxicity and ability to inhibit protein synthesis by
direct cytoplasmic expression. We show that mutations in α-sarcin, which impair α-sarcin's ability
to inhibit protein synthesis, do not affect its cytotoxicity. The mutants are unable to activate JNK,
confirming that the sarcin-ricin loop remains intact and that the α-sarcin mutants are catalytically
inactive. In addition, both mutant and wildtype variants of α-sarcin localize to the nucleus and
cytoplasm, where they co-localize with ribosomal marker RPS6.
Conclusion: We conclude that although protein synthesis inhibition likely contributes to cell
death, it is not required. Thus, our results suggest that α-sarcin can promote cell death through a
previously unappreciated mechanism that is independent of rRNA cleavage and JNK activation.
Background
α-Sarcin is a small fungal ribonuclease secreted by
Aspergillus giganteus. It functions as a ribonuclease by cat-
alytically cleaving a single phosphodiester bond in a well-
defined RNA motif (the sarcin-ricin loop) within the
rRNA scaffold of the large ribosomal subunit. This makes
the ribosome unrecognizable to elongation factors and in
turn, blocks protein synthesis [1]. In addition to its ability
to inactivate the ribosome, α-sarcin selectively interacts
with acidic phospholipids, and causes membrane fusion,
as well as aggregation of artificial liposomes [2-4]. α-
Sarcin's lipid binding properties allow for its uptake into
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the cell via acidic endosomes [4]. The mechanism of
endosomal escape has not been characterized, but Golgi
trafficking may be involved [5,6].
α-Sarcin induces cell death through apoptosis but the
mechanism is not completely understood [5]. It has been
reported that the toxicity of α-sarcin is due to catalytic
inactivation of the ribosome, and subsequent inhibition
of protein synthesis [5]. Studies in which purified recom-
binant α-sarcin is added to the exterior of cells have sup-
ported this conclusion and suggested that cleavage of the
sarcin-ricin loop within the ribosome is a prerequisite for
apoptosis in a manner that is JNK dependent [5,6].
Several mutagenesis studies have been conducted to iden-
tify the key residues critical for α-sarcin function. The
majority of these studies have been in vitro determina-
tions of α-sarcin enzymatic activity against ribosome con-
taining fractions or dinucleotide substrates. In vivo
analysis of α-sarcin activity has been limited to applica-
tion of purified α-sarcin to the exterior of the cells [4].
From these studies, and analogy to α-sarcin relative
RNAse T1, the catalytic mechanism of α-sarcin ribonucle-
ase activity has been elucidated. Cleavage within the rRNA
proceeds through a 2',3'-cyclic intermediate that is cata-
lyzed by hydrogen transfer from Histidine-137 to Gluta-
mate-96 [7]. This results in transphosphorylation in
which the phosphate group is shared between the 2' and
3' positions on the ribose ring [7]. The hydrolysis of this
cyclic derivative is catalyzed by these same two residues,
however, in this case, Glutamate-96 acts as a general acid,
and Histidine-137 acts as the general base [7]. Arginine-
121 has also been shown to be important for catalysis as
mutations in this residue render α-sarcin unable to cleave
ribosomal rRNA, although it retains significant activity
against dinucleotides [8]. Arginine-121 of α-sarcin is
thought to help position the substrate for catalysis [8].
In this report, we assayed α-sarcin cytotoxicity and its abil-
ity to inhibit protein synthesis by direct cytoplasmic
expression of the toxin in mammalian cells. We show that
mutations in α-sarcin, which impair α-sarcin's ability to
block translation of two independent reporters, retain the
ability to kill cells. We conclude that protein synthesis
inhibition is not necessary for α-sarcin to induce cell
death. Instead, our results indicate that α-sarcin can initi-
ate cell death independent of rRNA cleavage and JNK acti-
vation.
Results and discussion
We established a mammalian cell expression system to
directly assay the ability of α-sarcin to inhibit translation
and induce cell death by expressing the ribotoxin directly
in the cytoplasm of HeLa cells. Our objective was to deter-
mine the relative cytotoxicity of α-sarcin mutants inde-
pendent of effects due to toxin entry and trafficking. The
α-sarcin cDNA, and for comparison purposes, the ricin
toxin A chain cDNA, were cloned into the mammalian
expression vector, pcDNA3.1, where gene expression is
under control of the constitutive cytomegalovirus (CMV)
promoter. Ricin is a glycosidase which depurinates a
highly conserved adenine within the sarcin-ricin loop,
adjacent to the α-sarcin cleavage site [6]. HeLa cells have
been reported to be resistant to α-sarcin activity [9]. This
is presumably due to an inability of the toxin to enter
HeLa cells. To determine the sensitivity of HeLa cells to
direct ribotoxin expression, a dose response analysis was
carried out by transfecting cells with increasing amounts
of α-sarcin or ricin cDNA. Although both α-sarcin and
ricin transfected cells demonstrated a dose-dependent
decrease in viability at 48 hours, ricin was more effective
at low doses (50 ng) than α-sarcin (Figure 1a). This was
consistent with reported catalytic activities of α-sarcin and
ricin, with ricin demonstrating approximately 100-fold
greater catalytic activity than α-sarcin [10,11]. At concen-
trations greater than 250 ng, no further reduction in via-
bility was obtained and approximately 20% of the cells
remained viable. This was in keeping with our transfec-
tion efficiency in HeLa cells (70–85%), which was deter-
mined by transfection of pcDNA-GFP reporter plasmid
and counting the percentage of fluorescent cells (data not
shown). To examine the time course of toxin induced cell
death, HeLa cells were transfected with 250 ng of α-sarcin
or ricin cDNA, and cell viability was measured over a 48-
hour period. Exogenous expression of both α-sarcin and
ricin in HeLa cells resulted in decreased viability within 48
hours (Figure 1b). Both α-sarcin and ricin induced cell
death at similar rates, with ricin exhibiting slightly
enhanced cytotoxicity. Collectively, these results demon-
strate that direct cytoplasmic expression of α-sarcin and
ricin in mammalian cells is cytotoxic. We next examined
whether  α-sarcin catalytic activity was required for the
cytotoxicity observed during direct cytoplasmic expres-
sion.
Based on in vitro biochemical assays and cell culture exper-
iments performed with purified α-sarcin, it has been
reported that α-sarcin's toxicity is due to its catalytic abil-
ity to inactivate the ribosome and inhibit protein synthe-
sis [5]. We sought to determine whether catalytic activity
of α-sarcin is required for cytotoxicity when the toxin is
directly expressed in the cytoplasm of cells. We initially
characterized a catalytic mutant of α-sarcin,  α-sarcin-
R121Q [8]. Arginine 121 is located near the catalytic site
and although it is not directly involved in catalysis, it is
thought to help position the substrate in the correct orien-
tation for cleavage [8]. The α-sarcin-R121Q mutant is cat-
alytically attenuated based on in vitro biochemical assays
[8]. Despite its reduced catalytic ability in vitro, expression
of  α-sarcin-R121Q in HeLa cells resulted in a dose-BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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A) α-Sarcin and ricin induced cytotoxicity in HeLa cells is dose-dependent Figure 1
A) α-Sarcin and ricin induced cytotoxicity in HeLa cells is dose-dependent. HeLa cells were transfected with increas-
ing amounts of pcDNA3-α-sarcin or pcDNA3-ricin, and assayed for viability, relative to a pcDNA3 control, at 48 hours post-
transfection. B) HeLa cells were transfected with α-sarcin or ricin cDNA and assayed for viability, relative to a pcDNA3 con-
trol transfection, over a 48 hour time course. C) HeLa cells were transfected with increasing amounts of α-sarcin, α-sarcin-
R121Q, an N-terminal 3 × Flag-tagged-sarcin, or a C-terminal mychis-tagged-sarcin and assayed for viability, relative to a 
pcDNA3 control, at 48 hours post-transfection. Data represents the compiled results of at least 3 independent experiments, 
each performed in triplicate, +/- standard deviation.BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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dependent decrease in viability that was only slightly
reduced from that observed for wild-type α-sarcin (Figure
1c).
The cytotoxicity of α-sarcin-R121Q suggests that either
arginine-121 is not required for protein synthesis inhibi-
tion in cells, or that catalytic cleavage of the ribosomal
RNA is not necessary for α-sarcin-induced cytotoxicity. To
address this issue, we measured the ability of α-sarcin and
α-sarcin-R121Q to inhibit the translation of a co-trans-
fected GFP reporter. HeLa cells were transfected with toxin
cDNA, as well as a GFP reporter, and the extent of GFP
expression was monitored. The transfections were carried
out at high cell densities, as this was observed to delay α-
sarcin cytotoxicity (data not shown), and therefore, any
decrease in GFP levels could be attributed to inhibition of
translation, rather than a loss in total number of cells. In
addition, cells were examined microscopically prior to
analysis to confirm that the monolayers were of similar
density, and assays were conducted 18 hours after trans-
fection, before the onset of cell death (Figure 1b). Meas-
urement of GFP fluorescence in cell lysates showed that
GFP expression was inhibited relative to a vector control
in the wildtype α-sarcin and ricin transfected cells (Figure
2a). Measurement of GFP fluorescence in α-sarcin-R121Q
transfected cells revealed that the mutant was attenuated
with respect to its ability to inhibit GFP expression, which
is consistent with data implicating R121Q involvement in
catalysis (Figure 2a) [8]. We also generated an N-terminal
3 × Flag-tagged-α-sarcin (3 × Flag-sarcin) and C-terminal
mychis-tagged-α-sarcin (sarcin-mychis). While sarcin-
mychis exhibited near wild-type inhibition of GFP trans-
lation and toxicity, the 3 × Flag-sarcin was severely atten-
uated in both translation inhibition and toxicity (Figure
1c, 2a), despite robust expression levels (Figure 2c). The
N-terminal 22 amino acids of α-sarcin form a β-hairpin
that has been implicated in both the interaction with
membranes and in guiding the toxin to the sarcin-ricin
loop [12]. The attenuation of toxicity observed with the 3
× Flag-sarcin supports the importance of this region in α-
sarcin function.
The finding that α-sarcin-R121Q retained toxicity is con-
trary to the widely held view that ribotoxins induce apop-
tosis by blocking protein synthesis [1]. A possible
explanation for this result is that the R121Q mutant is
A) Inhibition of GFP reporter translation mediated by expression of protein toxins Figure 2
A) Inhibition of GFP reporter translation mediated by expression of protein toxins. HeLa cells were transiently co-
transfected with indicated toxin cDNAs and a GFP reporter. Inhibition of GFP translation, relative to pcDNA3/GFP co-trans-
fected cells, as determined by fluorimetric analysis of cell lysates. B) Exogenous expression of α-sarcin, α-sarcin-mychis, α-
sarcin-R121Q, and α-sarcin-R121Q-mychis in HeLa cells. Anti-sarcin western blot analysis of HeLa cell lysates transfected 
pcDNA3 or α-sarcin cDNA. * indicates the position of α-sarcin. R121Q mutant migrates slightly faster than wildtype α-sarcin. 
C) HeLa cells were transfected with either empty vector (MSCV) or 3 × Flag-sarcin. Stable cell lines expressing Flag-tagged-
sarcin were established. Anti-Flag western blot of MSCV or 3 × Flag-sarcin transfected cells. Charted data represents the com-
piled results of 3 independent experiments, each performed in triplicate, +/- standard deviation.BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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expressed to a greater extent. To rule out this possibility,
western blot analysis was performed to determine the lev-
els of toxin protein (Figure 2b). The levels of α-sarcin
detected using western blotting are invariably low and dif-
ficult to detect. Although the levels of the R121Q mutant
(both mychis and untagged) were slightly elevated com-
pared to wildtype, α-sarcin-R121Q was expressed at
equivalent levels to sarcin-mychis, which was comparable
to the wildtype α-sarcin in toxicity and translation inhibi-
tion. Therefore, we conclude that the levels of translated
toxin are unlikely to account for the observed toxicity of
the α-sarcin-R121Q mutant.
A second possible explanation for the toxicity associated
with α-sarcin-R121Q is that only a small decrease in pro-
tein synthesis is sufficient to induce cell death in HeLa
cells. Therefore to rule out any contribution of residual
catalytic activity of the R121Q mutant to the observed tox-
icity, we tested a second mutant, H137Q. As discussed,
Histidine-137 is essential for catalytic activity of α-sarcin,
acting as a general acid in the initial transphosphorylation
step of the hydrolysis reaction [7]. The H137Q has been
shown to be catalytically inactive against ribosomes and
dinucleotide substrates in vitro [7]. We tested the H137Q
mutant to determine if this catalytically defective mutant
was cytotoxic. Direct expression of α-sarcin-H137Q in
HeLa cells revealed that, similar to α-sarcin-R121Q, this
mutant is cytotoxic (Figure 3a). We measured its ability to
inhibit translation of the GFP reporter (Figure 3b) and a
second luciferase based reporter, in which luciferase
expression is under control of AP-1 promoter. Both GFP
and luciferase expression are inhibited by wildtype α-
sarcin, but not by either the R121Q or H137Q mutant
forms of α-sarcin (Figure 3c). To ensure the cytotoxicity
we observed for the α-sarcin-R121Q and H137Q was not
restricted to HeLa cells, we also expressed these mutants in
Cos7 cells. Direct expression of α-sarcin and the catalytic
mutants in Cos7 cells resulted in cytotoxicity (Figure 3F).
Our results are in contrast with a previous study using the
H137Q mutant that concluded that α-sarcin toxicity was
dependent upon its catalytic activity [5]. An obvious dif-
ference between this study and our own is that the previ-
ous study relied on adding purified α-sarcin to the media
of rhabdomyosarcoma cells and measuring the effect on
cell survival and protein synthesis. Since the mechanism
of α-sarcin entry and trafficking has not been fully eluci-
dated, one cannot be certain that this mutation does not
affect trafficking and, therefore, may not reach the cyto-
plasm to interact with the ribosome. By using direct cyto-
plasmic expression, we assessed toxicity independent of
trafficking. A second difference between this study and
our own is the cell line used. We have chosen two very dif-
ferent cell lines for our study – a human cervical cancer
epithelial cell line (HeLa) and an African green monkey
fibroblast SV40 transformed cell line (Cos7). Therefore,
our data is not cell type specific and the observed differ-
ences in cytotoxicity of the α-sarcin mutant between these
studies is likely due to a failure of the R121Q and H137Q
to properly traffic to the cytoplasm when added to the
exterior of the cell.
The 28S rRNA has been proposed to act as a sensor for
ribotoxic stress; α-sarcin has been shown to induce Jun N-
terminal kinase (JNK) activation and phosphorylation
through damage to the sarcin-ricin loop of the 28S rRNA
[6]. To test whether this pathway is important for the cyto-
toxic activity of the mutants, we assayed whether the α-
sarcin-R121Q and H137Q mutants could induce JNK acti-
vation by measuring JNK phosphorylation. As expected,
wild-type α-sarcin induced JNK phosphorylation (Figure
3d, e). However, despite the observed cytotoxicity of the
mutants, we did not detect an appreciable activation of
this pathway with either catalytic mutant (Figure 3d, e).
This is consistent with the notion that 28S rRNA damage
is responsible for initiating this stress response [6] and
rules out the possible explanation that the mutants retain
sufficient activity against the sarcin-ricin loop to induce
apoptosis through a JNK mediated stress response. Our
results indicate that the cytotoxicity of the mutants is not
due to a stress response caused by ribosome disruption.
Recent studies have shown that α-sarcin binds to the
ribosome through electrostatic interactions that lie out-
side of the catalytic site [13,14]. Therefore it is likely the
mutants still bind to the ribosome. To test this possibility,
we examined the subcellular localization of α-sarcin and
the mutants (R121Q shown) in relation to ribosomal
marker, RPS6. Both the wild-type α-sarcin and the
mutants localized to the nucleus and to a reticulate struc-
ture within the cytoplasm, which we determined colocal-
izes with ribosomal marker RPS6 (Figure 4a, b). A
substantial portion of α-sarcin is found within the
nucleus. At 17kDa, α-sarcin is expected to diffuse freely
through nuclear pore complexes. However, as far as we are
aware, this is the first demonstration that α-sarcin accu-
mulates in the nucleus, whether nuclear localization is
important for α-sarcin function is an open question.
α-Sarcin has been shown to kill cells by apoptotic induc-
tion [5]. To determine whether the cell death we observed
by direct expression was due to apoptosis, we measured
apoptosis in cells transfected with α-sarcin or each of the
mutants. As expected, wild type α-sarcin and both of the
mutants induced apoptosis 24 hours after transfection
(Figure 4c). We did not detect any difference in necrosis
between pcDNA3 controls and wild-type α-sarcin or
either of the mutants (data not shown).BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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Figure 3 (see legend on next page)BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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We have shown that two independent mutations within
the catalytic site of α-sarcin, which impair the catalytic
activity of the toxin, do not abrogate α-sarcin cytotoxicity
when expressed in cells. We conclude that α-sarcin cata-
lytic activity is not required for α-sarcin cytotoxicity, but it
is required to activate JNK in response to ribotoxic stress.
This is consistent with reports on the cytotoxicity of N-gly-
cosidase ribosome inactivating proteins, abrin and ricin
[15,16]. The N-glycosydic depurination activity of these
toxins occurs at a site near to the α-sarcin RNA cleavage
site. Abrin has been shown to interact with and inhibit
anti-oxidant protein-1 (AOP-1) [15]. This interaction
induces apoptosis by triggering an increase in reactive oxy-
gen species, independent of ribosome inactivation. Simi-
larly, in a yeast expression screen, Li et al. identified
mutants of ricin, which although catalytically active, were
not cytotoxic to yeast cells [16]. This implies that these
mutations affect protein interactions other than ricin's
catalytic interaction with the ribosome. Whether α-sarcin,
which is a ribonuclease, induces apoptosis through inter-
actions with other proteins remains an open question.
Since Arginine-121 and Histidine-137 lie within the cata-
lytic site and do not affect electrostatic interactions out-
side of the active site that are important for ribosomal
binding, an alternative explanation for our results is that
α-sarcin binding to the ribosome may be more important
than the catalytic inactivation of the ribosome [13,14].
The observed co-localization of α-sarcin and mutants with
ribosomal markers is consistent with this hypothesis.
It is intriguing that the 3 × Flag epitope on the N-terminus
of α-sarcin produced a catalytically inactive innocuous
toxin. Furthermore, we found that expression of an α-
sarcin with a deleted N-terminus was non-toxic (data not
shown). These results implicate the N-terminal β-hairpin
loop of α-sarcin in promoting cytotoxicity. Consistent
with this hypothesis, Garcia-Ortega et al. have shown that
deletion of the entire β-hairpin produces a catalytically
active toxin that is non-toxic [12]. This group showed that
the N-terminal β-hairpin was important for conferring
specificity towards the sarcin-ricin loop and suggested this
region may be important for ribosomal recognition. Oth-
ers have identified a sequence (15TNKYETK21) within the
N-terminus of α-sarcin that is conserved within all mem-
bers of the ribotoxin family. This resembles a sequence
found in elongation factors[17], which is further sugges-
tive that this region may be important in targeting α-
sarcin to the ribosome. It is possible that the addition of
the 3 × Flag epitope interferes with the ability of the N-ter-
minal β-hairpin to guide the toxin to the sarcin-ricin loop.
This would support the idea that binding to the ribosome
maybe more important for cytotoxicity than specific cleav-
age of the sarcin-ricin loop. Alternatively, similar to abrin,
α-sarcin may induce apoptosis through direct interaction
with a protein (or proteins) in the apoptotic pathway and
that the N-terminus of the toxin maybe important for this
interaction. Our data cannot exclude either possibility.
Intriguing, the N-terminus alone is not sufficient for
cytoxicity (data not shown) which suggests that if this
region is responsible for cytoxicity, it only functions
within the context of the whole protein. Further work is
needed to determine how the N-terminus influences cyto-
toxicity, and whether this is due to interaction with the
ribosome or other protein(s). The large-scale mutagenesis
approach used by Li et al. to isolate catalytically active,
non-toxic ricin mutants based on their inability to kill
yeast cells, would be ideally suited for identifying residues
that are required for α-sarcin cytotoxicity but not for cleav-
age of the sarcin-ricin loop [16].
Conclusion
In conclusion, our results highlight the importance of
direct expression analysis when characterizing protein
toxin mutations. They indicate that the ribotoxin α-sarcin,
similar to the plant ribosome inactivating proteins, ricin
and abrin, can directly induce cell death, independent of
its ability to inhibit protein synthesis. Thus, our results
suggest that α-sarcin can promote cell death through a
previously unappreciated mechanism that is independent
of rRNA cleavage and JNK activation. This is the first dem-
onstration of this independence within the ribonuclease
family. Our results suggest that contrary to the widely held
A) Wild type α-sarcin (wt) and the R121Q and H137Q mutants induced cytotoxicity in HeLa cells in a dose-dependent manner Figure 3 (see previous page)
A) Wild type α-sarcin (wt) and the R121Q and H137Q mutants induced cytotoxicity in HeLa cells in a dose-
dependent manner. HeLa cells were transfected with increasing amounts of toxin cDNA and assayed for viability, relative to 
a pcDNA3 control, at 48 hours post-transfection. B) Inhibition of GFP translation by α-sarcin wt, R121Q, or H137Q mutants 
determined by western blotting. C) Inhibition of firefly luciferase expression relative to pcDNA3/luciferase co-transfected cells, 
as determined by luminescence analysis of cell lysates. D) α-Sarcin wt induces JNK activation whereas the catalytic mutants do 
not. pJNK Western blot (arrow indicates position of JNK-2) HeLa cell lysates transfected with α-sarcin wt, R121Q mutant, 
H137Q mutant, 3 × Flag-sarcin or treated with vehicle (DMSO) or anisomycin for 20 minutes. Anisomycin is a potent agonist 
of JNK and is included as a positive control. (Bottom) For a loading control the above blot was stripped and reprobed with 
anti-JNK antibody. E) Quantification of JNK activation relative to pcDNA transfected controls as determined using a Li-Cor 
infrared imager. Charted data represents the compiled results of 3 independent experiments, each performed in triplicate, +/- 
standard deviation. F) Relative viability of Cos 7 cells transfected with pcDNA3-α-sarcin (wt) or R127Q, or H137Q mutants.BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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view, protein synthesis inhibition by α-sarcin is insuffi-
cient to induce apoptosis and will interest those individu-
als developing inhibitors of ribotoxins, using ribotoxins
for cancer therapy, as well as those interested in under-
standing ribosome function.
Methods
Cloning of α-sarcin and α-sarcin mutants
α-Sarcin cDNA was cloned by consecutive annealing of
overlapping primers followed by ligation into XhoI- and
HindIII-sites in pcDNA3.1 or pcDNA3-mychis vector (C-
terminal MycHis tag). In addition, α-sarcin cDNA was
cloned into 3 × FLAG pMSCV to obtain a N-terminal 3 ×
Flag tagged version of α-sarcin.  α-Sarcin mutants were
generated by overlap extension PCR. All α-sarcin clones
were characterized by DNA sequencing.
Cloning of ricin
A  Ricinus communis specimen bearing seedpods was
obtained from a local nursery. Seed coats were removed
A) Colocalization of α-sarcin with ribosomal marker RPS6 Figure 4
A) Colocalization of α-sarcin with ribosomal marker RPS6. HeLa cells were transfected with α-sarcin-mychis cDNA 
(wt) and after 24 hours, fixed and labeled with anti-myc (FITC channel) and anti-RPS6 (rhodamine channel). (Bar 10 μM) B) 
Localization of the R121Q-mychis tagged mutant form of α-sarcin. The localization of both mutants appeared identical to wild-
type α-sarcin. (Bar 10 μM) C) α-sarcin, and the R121Q and H137Q mutants induce apoptosis. Cos7 cells were transfected 
with pcDNA3, α-sarcin wildtype (wt), α-sarcin R121Q, or α-sarcin H137Q. After 24 hrs cells were collected and analyzed for 
annexinV-FITC and propidium iodide staining using FACS.BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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and approximately 0.5 grams of seed tissue was ground
using a small mortar and pestle. The sample was homog-
enized in TRIzol® reagent (Invitrogen) using a PowerGen
125 homogenizer. TRIzol® extraction of total RNA was
performed using an RNA extraction kit according to the
manufacturer's protocol (Invitrogen).
Reverse-transcriptase (RT)-PCR reactions were performed
according to the manufacturer's instructions (Protoscript®
II RT-PCR Kit, New England Biolabs). First strand cDNA
synthesis reactions contained nuclease-free water, 100
pmol oligo-dT primer, 200 μM dNTPs, 1× RT buffer, 10 U
RNase inhibitor, 750 ng R. communis RNA, and 5.0 U M-
MuLV Reverse Transcriptase (RT). PCR amplification was
performed on 2 μl of cDNA using Deep VentR
TM DNA
polymerase (New England Biolabs). The ricin cDNA was
cloned into XhoI- and HindIII-treated pcDNA3.1 and
sequenced.
SDS-page and western blotting
Whole cell lysates were harvested, cells were washed once
with phosphate-buffered saline (PBS; 0.2 M NaCl, 4.2
mM KCl, 12.7 mM Na2HPO4, 2.3 mM KH2PO4) and cell
lysis was performed using NP-40 lysis buffer (20 mM Tris
pH 8.0, 137 mM NaCl, 10% glycerol, 1% nonidet-P40, 2
mM EDTA).
Whole cell lysates were combined with an equal volume
of 2× SDS-PAGE sample buffer (125 mM Tris pH 6.8, 4%
SDS, 150 mM DTT, 14% glycerol, 0.04% bromophenol
blue) and heated at 95°C for ten minutes prior to electro-
phoresis. SDS-PAGE was performed according to the
method of Laemmli [18]. Protein samples were resolved
through 11% SDS-PAGE gels and transferred to nitrocel-
lulose membranes (0.45 μm) using Towbin transfer
buffer (25 mM Tris pH 8.3, 192 mM glycine, 20% (w/v)
methanol). Membranes were blocked using 5% skim milk
in Tris buffered saline (20 mM Tris-HCl pH 7.4, 137 mM
NaCl, 0.1% Tween-20). After incubation with primary
antibodies, proteins were detected using an Enhanced
Chemiluminescence western blotting detection system
(Amersham).
Mammalian cell culture
HeLa and Cos 7 cell lines were cultured in Dulbecco's
Modified Eagle Medium (DMEM) with 10% fetal bovine
serum, 100 μg/mL penicillin and 100 μg/mL streptomycin
at 37°C and 5% CO2 according to standard procedures.
To assay relative cell viability over time, HeLa cells were
seeded at 2 × 104 cells/well in a 24-well dish. Twenty-four
hours later, transient transfection of the appropriate plas-
mids was carried out using lipofectamine reagent (Invitro-
gen) according to the manufacturer's instructions. For
experiments in which the amount of α-sarcin and ricin
cDNAs were varied, the total amount of plasmid in the
transfection was held constant by substituting the appro-
priate amount of pcDNA3.1 vector.
Protein synthesis inhibition (GFP reporter)
To assay protein synthesis inhibition, HeLa cells were
seeded at 3.0 × 104 cells/well in a 24-well dish. Twenty-
four hours later, transient transfection of a GFP reporter
plasmid, AdTrack CMV (250 ng), along with the appropri-
ate α-sarcin cDNA, was carried out as described above.
Eighteen hours after transfection, cell lysates were har-
vested and analyzed by fluorimetric analysis (excitation
485 nm/emission 535 nm) using a VictorTM
3V 1420 Mul-
tilabel counter (Perkin Elmer). Percentage protein synthe-
sis inhibition was calculated as 1-(RFUtoxin/RFUvector
control). Fluorescence analysis represents data from at least
three independent experiments performed in triplicate.
Cell viability assay
To assay dose-dependent killing, HeLa cells were seeded at
2 × 104 cells/well in a 24-well dish. Twenty-four hours
later, transient transfection of the appropriate plasmids
was carried out. Amounts of 50, 100, 250, and 500 ng of
toxin plasmid DNA were transfected. Where required,
control vehicle plasmid (either pcDNA3.1 or pMSCV) was
added to the transfection mix to control for the amount of
DNA transfected (500 ng per well). Forty-eight hours fol-
lowing transfection, relative cell viability was assayed by
crystal violet staining (described below). Briefly, cells cul-
tured in a 24-well dish were washed once with PBS and
fixed with 10% formalin for 10 minutes at room temper-
ature. Cells were washed two times with distilled water
(dH2O) and incubated with 0.1% crystal violet for 30
minutes at room temperature. To remove excess stain,
cells were extensively washed with dH2O. Crystal violet
was extracted using 10% acetic acid. Extracts were diluted
1:4 and their absorbance was measured at 595 nm using a
VictorTM
3V 1420 Multilabel plate reader. Percentage via-
bility was determined as the ratio of the A595 nm of toxin-
transfected cells to the A595 nm of pcDNA3.1-transfected
control cells. Data represents at least three independent
experiments, each performed in triplicate.
JNK activation assay
HeLa cells were seeded at 1 × 105 cells/well in 12-well dish
(1 mL). Twenty-four hours later, cells were transiently
transfected with 1 ug plasmid DNA and Lipofectamine
2000 reagent as per manufacturer's instructions. After 12
hrs of incubation, cells were lysed in 1% NP-40 lysis
buffer. For control wells, cells were treated with DMSO
(vehicle) or anisomycin (200 ng/mL) for 20 minutes prior
to lysis. Phosphorylated JNK and JNK were detected by
Western blotting with rabbit anti-pJNK (T183/Y185) and
anti-JNK antibodies (Cell Signaling Technologies) and
visualized with HRP conjugated secondary antibodies
(Jackson ImmunoResearch). JNK activation was quanti-BMC Biochemistry 2009, 10:9 http://www.biomedcentral.com/1471-2091/10/9
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fied using IRDye700DX conjugated secondary antibodies
(Rockland) on a Li-Cor Odyssey Infrared Imager running
version 2.1 software. Activation of JNK by WT or α-sarcin
mutants was made relative to vector (pcDNA3.1) trans-
fected cells. Error bars represent standard deviation of 3
independent analyses.
α-Sarcin localization
HeLa cells were seeded at 5 × 105 cells/well in 6-well dish
(1 mL) containing a coverglass slip that had been pre-
coated with fibronectin. Twenty-four hours later, cells
were transiently transfected with 5 ug plasmid DNA and
Lipofectamine 2000 reagent as per manufacturer's instruc-
tions. After 24 hours, cells were washed in PBS, fixed in
3.7% formalin/PBS, and permeablized with 0.1% Triton
X-100. The cells were blocked in 3% BSA/PBS for 1 hour
at room temperature and then incubated with either anti-
myc (1:500 dilution) and anti-RPS6 (1:500 dilution) anti-
bodies. To detect primary antibody binding, the cells were
then incubated with Alexa-Fluor 488 anti-mouse (Molec-
ular Probes) to detect Sarcin-mychis and Rhodamine anti-
rabbit (Molecular Probes) to detect RPS6. Images were
captured using a Leica DMIRE2 inverted fluorescent
microscope with OpenLab V software. Z stacks were
imaged at 0.3 uM intervals and deconvolved using nearest
neighbor deconvolution.
Apoptosis assay
Cos7 cells were grown to 75% confluency and transiently
transfected as described above using 10 ug of vector
(pcDNA 3.1) or α-sarcin (WT or mutant) plasmid DNA
and Lipofectamine 2000 according to the manufacturer's
instruction. At 24 hours post-transfection, cells were
scraped and pelleted, washed once in PBS, and resus-
pended in 1× Annexin Binding buffer (FITC Annexin V
Apoptosis Detection Kit, BD Pharmigen). Cells were
stained for flow cytometry using Annexin V-FITC and Pro-
pidium Iodide according to manufacturer's instructions
(BD Pharmigen) and sorted on a BD FACSCalibur system
(BD Biosciences).
Luciferase assay
HeLa cells were seeded at 3 × 105 cells/well in a 6-well
dish. Twenty-four hours later, cells were transiently trans-
fected with 6.5 ug vector plasmid DNA (background con-
trol) or 3 ug pAP1-Luciferase, 0.5 ug pHRCTK (Renilla)
and 3.5 ug vector (pcDNA3.1) or α-sarcin (WT or mutant)
plasmid DNA and Lipofectamine 2000 reagent as per
manufacturer's instructions. After 18 hrs of incubation,
cells were removed from the plate by trypsinization and
counted. Approximately 1.5 × 105 cells were taken and
luciferase levels determined using the Dual-Glo Luciferase
Assay Kit (Promega) on a Victor3V Multilabel plate reader.
Samples were analyzed in triplicate. Percentage protein
synthesis inhibition was calculated as 1-(RLUtoxin/RLUvec-
tor control). Error bars represent standard deviation of 3
independent analyses each performed in triplicate.
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